Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

931 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects (2019, background): “For instance, CUR modulates tumor growth via regulating multiple signaling pathways, including cell survival, tumor suppressor, caspase pathways, protein kinase, and death receptor pathways [5,7,19].”
Polyphenols: A concise overview on the chemistry, occurrence, and human health (2019, background): “Starting from the first clinical trial published in The Lancet in 1937 (Oppenheimer, 1937), more than 1,200 clinical trials involving more than 6,000 subjects have been carried out, and many systematic reviews have been published (Kunnumakkara et al., 2017).”
A Review of Curcumin and Its Derivatives as Anticancer Agents (2019, background): “The main mechanisms of action by which curcumin exhibits its unique anticancer activity include inducing apoptosis and inhibiting proliferation and invasion of tumors by suppressing a variety of cellular signaling pathways [10].”